Department of Pediatrics, University of Zagreb School of Medicine, Zagreb, Croatia.
Division of Clinical Immunology and Rheumatology, Department of Pediatrics, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
BMC Pediatr. 2021 Jan 15;21(1):40. doi: 10.1186/s12887-021-02494-6.
The last two decades brought new treatment options and high quality guidelines into the paediatric rheumatologic practice. Nevertheless, a number of patients still present a diagnostic and therapeutic challenge due to combination of vague symptoms and unresponsiveness to available treatment modalities.
We report a case of sixteen years old girl suffering from polyarticular type of juvenile idiopathic arthritis refractory to multiple treatment options. She first presented at the age of 4 with swelling and contractures of both knees. Her symptoms were initially unresponsive to nonsteroidal anti-inflammatory drugs and progressed despite treatment with intraarticular and systemic glucocorticoids and methotrexate. Throughout the years, she received several biologics together with continuous administration of nonsteroidal anti-inflammatory drugs and disease modifying anti-rheumatic drugs as well as intraarticular and systemic glucocorticoids in disease flares. However, none of this options provided a permanent remission, so various other modalities, as well as other possible diagnoses were constantly being considered. Eventually she became dependent on a daily dose of systemic glucocorticoids. In 2018, the treatment with Janus kinase inhibitor tofacitinib was initiated, which led to gradual amelioration of musculoskeletal symptoms, improvement of inflammatory markers and overall well-being, as well as to the weaning of systemic glucocorticoids. As the swelling of the wrists subsided for the first time in many years, Madelung's deformity was noticed, first clinically, and later radiographically as well. Genetic analysis revealed short-stature homeobox gene deficiency and confirmed the diagnosis of Leri Weill syndrome.
This case report emphasizes the need for reporting refractory, complicated cases from everyday clinical practice in order to build-up the overall knowledge and share experience which is complementary to available guidelines. Individual reports of difficult to treat cases, especially when additional diagnoses are involved, can be helpful for physicians treating patients with common rheumatological diseases such as juvenile idiopathic arthritis.
过去二十年为儿科风湿学实践带来了新的治疗选择和高质量的指南。然而,由于模糊的症状和对现有治疗方法的无反应,许多患者仍然存在诊断和治疗挑战。
我们报告了一例 16 岁女孩,患有幼年特发性关节炎多关节型,对多种治疗方法均无反应。她首次于 4 岁时出现双侧膝关节肿胀和挛缩。她的症状最初对非甾体抗炎药无反应,尽管接受了关节内和全身糖皮质激素以及甲氨蝶呤治疗,病情仍在进展。多年来,她接受了几种生物制剂,同时持续使用非甾体抗炎药和改善病情的抗风湿药以及关节内和全身糖皮质激素治疗疾病发作。然而,这些方法都没有提供永久性缓解,因此不断考虑其他各种方法以及其他可能的诊断。最终,她依赖于每日全身糖皮质激素剂量。2018 年,开始使用 Janus 激酶抑制剂托法替尼治疗,这导致肌肉骨骼症状逐渐改善,炎症标志物和整体健康状况改善,以及全身糖皮质激素逐渐减量。由于多年来首次手腕肿胀消退,注意到马德隆畸形,首先是临床,后来是放射学。基因分析显示短身高同源盒基因缺陷,证实了 Leri-Weill 综合征的诊断。
本病例报告强调需要报告日常临床实践中难治性、复杂病例,以建立整体知识并分享经验,这些经验是对现有指南的补充。对于治疗常见风湿病(如幼年特发性关节炎)的医生来说,涉及额外诊断的难治性病例的个别报告可能会有所帮助。